Clinical Governance & E-E-A-T Assurance

Medical Advisory & Review Board

All clinical walkthroughs, billing explanations, and cross-border patient procedures published on China Med Visit undergo systematic scrutiny by our multidisciplinary medical advisory board. Our reviewers verify that procedural guidance aligns with current Chinese clinical practice and international patient safety standards.

Dr. Lin Zhao, MD, PhD

MD (PUMCH), PhD in Clinical Oncology, Member of CSCO
Senior Medical Advisor & Cross-Border Clinical Liaison · Formerly Peking Union Medical College Hospital (PUMCH)

Dr. Zhao has over 18 years of clinical experience in oncology and tertiary hospital administration in Beijing. He oversees factual accuracy across our procedural guides, hospital department qualifications, and bilingual clinical terminology.

Areas of Clinical Expertise
Clinical OncologyImmunotherapy ProtocolsInternational Patient Triage
Active Review Board MemberReview Cycle 2026

Dr. Sarah Jenkins, MD, MPH

MD (Johns Hopkins), MPH (Harvard Chan), Fellow of ACP
International Patient Safety & Insurance Adjudication Advisor · Global Health Practice Group, Former Medical Director of International SOS Beijing

Dr. Jenkins specializes in expatriate healthcare transitions, emergency repatriation protocols, and cross-border commercial insurance pre-authorizations between Western insurers and Chinese Tier-3A IMCs.

Areas of Clinical Expertise
Cross-Border Care CoordinationGOP Direct BillingMedical Evacuation & Travel Fitness
Active Review Board MemberReview Cycle 2026

Dr. Michael Chen, MD, FACS

MD (Fudan University), FACS (Fellow of American College of Surgeons)
Surgical Procedures & Minimally Invasive Technology Advisor · Huashan Hospital Worldwide Medical Center Affiliate

Dr. Chen provides expert review on specialist referral pathways, second opinion dossiers, surgical lead times, and post-operative recovery timelines in Shanghai tertiary medical hubs.

Areas of Clinical Expertise
Minimally Invasive SurgeryOrthopedic RehabilitationTier-3A Specialist Access
Active Review Board MemberReview Cycle 2026

Reviewer Charter & Scope of Responsibility

  • 1.Factual Medical Procedures: Validate that outpatient steps, triage rules, and medication dispensing procedures accurately reflect Chinese hospital operations.
  • 2.Patient Safety Warnings: Ensure critical contraindications, travel fitness criteria, and insurance GOP verification risks are explicitly stated.
  • 3.Independence from Commercial Bias: Advisory members do not receive commissions from specific hospitals or treatment programs.